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Pregnancy in women with type 1 diabetes remains 
a challenge for the patient and healthcare team 
alike. The scenario box on this page highlights 
some of the problems in achieving satisfactory 
pregnancy outcomes in women with diabetes. We 
discuss in the article the main areas of concern.
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Planning for pregnancy
The most important aim is to achieve the best pos-
sible glycaemic control before pregnancy. Over the 
past two decades intensive efforts to offer individual 
education about this have not resulted in higher 
prepregnancy counselling rates or even in presentation 
before the critical 42 day period of organogenesis.1-3 w1 w2 
The St Vincent declaration, a joint declaration 
by all European governments on preventing the 
problems of diabetes, outlined an aim of achieving 
similar outcomes of pregnancy in diabetic and non- 
diabetic women. This aim has not been met in most 
countries,2 w3 although a “planned pregnancy” rate of 
84% among diabetic women across the Netherlands 
has been reported.w4 A modest rise in planned 
pregnancy rates has been reported in one United 
Kingdom centre.4 w5  An approach that raises awareness 
in the general population may be needed to promote 
further behaviour change in the UK.
For women with established diabetic nephropathy 
the chance of successful pregnancy diminishes 
sharply as serum creatinine increases (80% chance 
if 125-180 µmol/l; 75% chance if 180-220 µmol/l; 
and 60% chance if >220 µmol/l).w6 The higher the 
prepregnancy creatinine concentrations, the higher 
the risk of permanent loss of renal function. When 
albuminuria is established in a woman with type 1 
diabetes, the implications for timing of pregnancy 
should be explained to her. Diabetic nephropathy 
will inevitably advance, and renal function will 
decline over a period of months or years. Once the 
creatinine concentration has increased, the chance 
of successful pregnancy decreases.
How does pregnancy affect diabetes? 
Control in type 1 diabetes is achieved by matching 
insulin dose with food intake and the changing 
insulin sensitivity. In early pregnancy, morning 
sickness may disrupt normal eating, and changes 
in timing or dose of insulin may be required; for 
women on a basal bolus-type regimen, this is 
relatively simple. Access to telephone advice from 
the diabetes team is important over this most critical 
phase of pregnancy.
Insulin dose requirements change in pregnancy 
as a consequence of the physiological increase in 
insulin resistance. The extent of increase is 
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ScenarIo
Julie rang the diabetes specialist nurse having confirmed 
pregnancy with a home test kit. Her period was two weeks 
late. Although she recalled being advised about the need 
for prepregnancy care, she thought her glucose control 
was good enough (HbA1c concentration 7.9% at last check) 
and she had been taking a 400 µg tablet of folic acid daily. 
She had developed type 1 diabetes 16 years before (at 
age 8) and at her last annual review had no retinopathy 
or microalbuminuria. She controlled her diabetes with 
bedtime insulin glargine, plus insulin lispro (a rapid acting 
analogue) before meals. 
An urgent appointment for the medical obstetric 
clinic was arranged, and telephone advice was given to 
achieve blood glucose levels of 3.5-5.5 mmol/l before 
meals and 4.0-6.5 mmol/l two hours after meals. HbA1c 
concentration decreased from 7.7% at presentation to 
6.3% within eight weeks and was maintained around this 
level for the rest of pregnancy. The 19-20 week anomaly 
scan showed a cardiac abnormality, later confirmed 
with fetal echocardiography as a ventricular septal 
defect. Blood pressure increased from 102/66 mm Hg 
to 124/84 mm Hg. Labour was induced at 38 weeks. 
Blood glucose concentration was maintained at between 
5.5 mmol/l and 7.3 mmol/l through use of intravenous 
glucose and insulin. After a normal vaginal delivery the 
4100 g baby boy had Apgar scores of 7 and 9 at 1 and 5 
minutes respectively. The locum neonatal senior house 
officer was advised by the experienced midwives not to 
measure blood glucose at birth, and when it was checked 
three hours after the first feed it was normal for age (2.8 
mmol/l). Julie’s baby remained with her on the ward. 
The paediatric cardiologist advised that no immediate 
cardiology intervention was required but follow-up was 
arranged. Julie was able to resume normal eating and 
subcutaneous insulin immediately after delivery.
MeTHoDS
In writing this review, we used published information from 
Medline searches, search of the Cochrane databases, and 
personal reference archives 
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wdetermined by placental function and varies in 
successive pregnancies in any one woman. A five 
year, single centre, observational study has shown that 
the average increase in insulin requirement is 40%, 
with a wide range from no change to a higher than 
threefold increase.5 Figure 1 shows the average time 
course of this change, which is helpful for advising 
what is to be expected from each clinic visit. Box 1 
summarises the effects of pregnancy on diabetes. 
One consequence of achieving near normoglycae-
mia is that asymptomatic hypoglycaemia will occur 
more frequently, and this will lead to unawareness 
of hypoglycaemia.w7 Women must be advised that 
they are at greater risk than usual of severe, una- 
nnounced hypoglycaemia and be specifically cou- 
nselled about the importance of testing blood glucose 
concentrations before driving. Ideally a spouse or 
partner should be provided with a glucagon kit and 
trained in its use.
Retinopathy deteriorates whenever blood glucose 
control is suddenly tightened, as shown by several 
large randomised studies.6 w8 In pregnancy, the extent 
of deterioration is strongly related to the degree of 
retinopathy present just before pregnancy. If 
retinopathy is not present on digital imaging 
according to the national standards for England,7 
then it is highly unlikely that clinically significant 
change wil l  occur during pregnancy.w9-w11 
Rechecking at 28 weeks’ gestation is all that is 
required. However, if moderate background changes 
are present, over half of women will develop prolif-
erative retinopathy,w11 and full retinal screening is 
required at booking, 16-20 weeks, and 28 weeks.
If diabetic nephropathy is already established and 
serum creatinine is raised, there is an increased risk 
of permanent loss of renal function.w12
How does diabetes affect the pregnancy? 
The most profound potential effect is the increased 
risk of congenital malformations. The recent UK 
Confidential Enquiry into Maternal and Child 
Health survey showed a threefold excess of cardiac 
and neural tube anomalies.8 Figure 2 shows that 
very poor control of blood glucose leads to over 
25% risk of malformation but that improved 
prepregnancy glucose control can decrease this 
almost to background levels.w13-w15 Even women with 
type 1 diabetes with normal HbA1c concentrations 
have intermittent, marked hyperglycaemia, and this 
may explain the difficulty of completely minimising 
the risk.w16 w17 
Hyperglycaemia exerts its teratogenic effects 
during the period of organogenesis—the first 42 days 
of pregnancy—and pregnancy is invariably con-
firmed when much of this time has elapsed. This, 
together with delays in seeking advice from a nurse 
or doctor, means that frequently no effective advice 
to modify risk of congenital malformations can be 
given during the pregnancy. Diabetes confers a sig-
nificant increase in risk of early spontaneous fetal 
loss, often as a consequence of non-viable, severe 
malformation.w13
Prepregnancy care from specialised multidiscipli-
nary clinics, involving optimisation of blood glucose 
control and prescription of folic acid, could con-
siderably decrease the observed rates of congenital 
malformation. Regrettably, however, even energetic 
local programmes have only modest impact at best,1 4 
and data from countries round the world suggest 
that achieving change is very difficult.2 3 w1 w18 Many 
patient information leaflets about pregnancy do not 
make clear the risks of pregnancy in diabetes. It is 
now routine practice to advise women to take 5 mg 
Box 1 | effects of pregnancy on diabetes 
• Change in eating pattern
• Increase in insulin dose requirements at 18-28 weeks’ 
gestation
• Greater importance of tight glucose control (ideally HbA1c 
<6.1%)
• Increased risk of severe hypoglycaemia
• Risk of deterioration in pre-existing retinopathy
• Risk of deterioration of established nephropathy
• Lower renal threshold for glycosuria
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Fig 1 | Data on 107 singleton pregnancies (showing means 
with standard deviations), from Taylor et al.5 average insulin 
dose does not change until around 18 weeks’ gestation and 
then increases steadily until around 28 weeks’ gestation. The 
average fall in insulin dose of 5% between weeks 34 and 38 
conceals wide individual variation 
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Fig 2 | The risk of all congenital malformations is increased 
above the background population rate of 2%, even in women 
with type 1 diabetes with normal Hba1c concentrations. The 
risk increases sharply with increasingly poor blood glucose 
control. Data from rosenn et alw13
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of folic acid daily before conception and for the first 
12 weeks of pregnancy. No direct evidence supports 
this advice; the consensus to offer such advice w19 w20 
was extrapolated from information that increased 
folic acid intake is more effective in preventing mal-
formations in other conditions of high risk of neural 
tube defects.w21
Macrosomia (birth weight >4000 g) occurs in 
about a fifth of pregnancies in women with type 
1 diabetes—twice the incidence for Englandw22— 
with the important corollary of an increased risk of 
birth injury to such babies. Shoulder dystocia occurs 
in about 8% of births to diabetic mothers (with risk 
of Erb’s palsy), compared with 3% to the background 
population as shown by large, well conducted obser-
vational studies.2 w4 Associated with macrosomia is 
the greater risk of more severe trauma to the mother, 
with potential future problems of poor pelvic floor 
function. Serial monitoring of fetal growth and size 
by ultrasonography is essential to allow judicious 
planning of delivery.
Delivery at about 38 weeks’ gestation is advised 
for women with diabetes to minimise the risk of 
unexplained late fetal death. The timing and mode 
of delivery should be determined on an individual 
basis based on best possible assessments of risk to 
mother and baby. Macrosomia might also be a factor 
influencing timing of delivery, although little evi-
dence supports this.w23 In recent published series, 
delivery before 37 weeks occurred in about a third of 
women with type 1 diabetes, with preterm caesarean 
section being the greatest single contributor.5 8 w24
Pre-eclampsia is four times more likely to occur in 
women with type 1 diabetes than in women without 
diabetes,9 and even more likely in the presence of 
nephropathy (if albuminuria or microalbumuria has 
been established before pregnancy).w25 A large obser-
vational study has shown that poor blood glucose 
control before pregnancy does not in itself increase 
the likelihood of pre-eclampsia, although persistent 
poor control during pregnancy does increase the risk 
(odds ratio 1.65 for each 1% increase in HbA1c).
w5
Box 2 summarises the effects of diabetes on 
pregnancy.
How should drug treatment be managed?
The use of the recently introduced long acting 
insulin analogue glargine is one of the most impor-
tant recent advances in diabetes management as it 
minimises the risk of hypoglycaemia despite tight 
control.10 Two case series totalling 174 individuals 
have shown no safety problems in pregnancy.w26 w27 
Given that swings of blood glucose are known to be 
deleterious, any safety problems specific to glargine 
are outweighed by the beneficial effects on overall 
control. Like most insulins, glargine is not licensed 
specifically for use in pregnancy, and individuals 
must be advised about risks and benefits. There is no 
single insulin regimen that suits all in pregnancy.
If a patient is taking antihypertensive treatment 
such as an angiotensin converting enzyme inhibitor 
before pregnancy, then this should be tailed-off as 
soon as possible because of the risk of congenital 
malformations.w28 Methyldopa should be substituted 
providing that continuing treatment is required.
Treatment with high dose steroids may be 
required to mature the fetal lung if delivery is nec-
essary before 34 weeks’ gestation, for asthma, or 
for hyperemesis gravidarum. If treatment is indi-
cated, the inevitable and predictable increase in 
insulin resistance requires a prospective increase in 
insulin dosage. In practice, an increase of 40% at 
the time of the first dose will prevent loss of con-
trol.w29 The increased dose of insulin is required 
until 24 hours after the last steroid dose. This 
will prevent the gross hyperglycaemia otherwise 
precipitated and is extremely unlikely to cause 
hypoglycaemia.
Management of mother and baby around delivery
The risk of neonatal hypoglycaemia is increased 
in the presence of maternal diabetes, as the 
maternal hyperglycaemia triggers excessive 
rates of insulin synthesis by the fetal pancreas. 
The risk does not correlate with HbA1c during 
pregnancy.1 5 However, controlling maternal blood 
glucose over the few hours before delivery is 
critical to minimise the risk of neonatal hypogly- 
caemia as blood glucose concentrations higher than 
8 mmol/l will almost inevitably be associated with 
neonatal hypoglycaemia.5 Hence, maternal blood 
glucose concentrations of 4-8 mmol/l should be 
achieved using glucose and insulin infusion.1 As soon 
as the cord is cut, the rate of insulin infusion should 
be halved as insulin sensitivity returns to normal 
within minutes of shut-down of the uteroplacental 
circulation. Subcutaneous insulin administration can 
be resumed as soon as the mother is able to eat.
If the baby’s blood glucose is checked as a routine 
precaution too early in life, then low concentrations 
are certain to be observed (5% of babies of non-dia-
betic women have a blood glucose concentration of 
less than 1.7 mmol/l within two hours of birthw30 w31). 
When faced with maternal diabetes, inexperienced 
staff tend to check the neonate’s blood glucose, with 
the consequence that the baby will be unnecessarily 
admitted to a special care unit and the mother 
left alone on the ward after nine months of hard 
struggle with diabetes. To avoid this “empty arms 
syndrome” it is critical to promote early feeding, 
with a check of blood glucose only just before 
the second feed. This will decrease the current 
Box 2 | effects of diabetes on pregnancy 
• Need for pregnancy planning
• Risk of congenital malformation
• Risk of macrosomia
• Need for regular clinical and ultrasound monitoring
• Increased risk of pre-eclampsia
• Increased risk of miscarriage and intrauterine death
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separation rate (one in three cases)—two thirds of 
separations are potentially avoidable. If hypogly- 
caemia is suspected, however, then glucose concen-
trations should be checked.
Conclusions
If Julie (see Scenario box) had contacted her diabetes 
team before going ahead with her plans to conceive 
and if blood glucose control had been optimised, the 
risk of congenital malformation would have been 
much reduced. Care from the combined obstetric 
and diabetes team during pregnancy indeed allowed 
early detection of problems. The induction of labour 
at 38 weeks avoided the potential risk of unexplained 
late fetal death. Good blood glucose control during 
labour minimised the chance of neonatal hypogly-
caemia, and separation of mother and baby after 
delivery was avoided.
We thank Sally Marshall for discussion about this article.
Competing interests: None declared.
provenance and peer review: Commissioned and peer reviewed.
1  Carron-Brown S, Kyne-Grzebalski D, Mwangi B, Taylor R. Effect of 
management policy upon 120 type 1 diabetic pregnancies: policy 
decisions in practice. Diabet Med 1999;16:573-8.
2  Penney GC, Mair G, Pearson DW. Outcomes of pregnancies in 
women with type 1 diabetes in Scotland: a national population-
based study. BJOG 2003;110:315-8.
3  Jensen DM, Damm P, Moelsted-Pedersen L, Ovesen P, Westergaard 
JG, Moeller M, et al. Outcomes in type 1 diabetic pregnancies: 
a nationwide, population-based study. Diabetes Care 
2004;27:2819-23.
4  Temple RC, Aldridge VJ, Murphy HR. Prepregnancy care and 
pregnancy outcomes in women with type 1 diabetes. Diabetes 
Care 2006;29:1744-9.
5  Taylor R, Lee C, Kyne-Grzebalski D, Marshall SM, Davison JM. 
Clinical outcomes of pregnancy in women with type 1 diabetes. 
Obstet Gynecol 2002;99:537-41. 
6  Group DR. Early worsening of diabetic retinopathy in the diabetes 
control and complications trial. Arch Ophthalmol 1998;116:874-
86.
7  National screening programme for sight-threatening diabetic 
retinopathy. www.nscretinopathy.org.uk/pages/nsc.
asp?ModT=A&Sec=16  
8  Confidential enquiry into maternal and child health. pregnancy in 
women with type 1 and type2 diabetes in 2002-03. England, Wales 
and Northern Ireland. London: CEMACH, 2005.
9  Feig DS, Razzaq A, Sykora K, Hux JE, Anderson GM. Trends in 
deliveries, prenatal care, and obstetrical complications in women 
with pregestational diabetes: a population-based study in 
Ontario, Canada, 1996-2001. Diabetes Care 2006;29:232-5. 
10 Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA. Less 
hypoglycemia with insulin glargine in intensive insulin therapy 
for type 1 diabetes. US Study Group of Insulin Glargine in Type 1 
Diabetes. Diabetes Care 2000;23:639-43.  
suMMARy OF ClInICAl MAnAgEMEnT  
In EACH TRIMEsTER
First trimester
• Blood glucose control
• Folic acid 5 mg once daily
• Digital retinal screening
• Treat asymptomatic bacteriuria if present
Second trimester
• Blood glucose control
• Anomaly scan with tertiary centre assessment as needed
Third trimester
• Blood glucose control
• Serial ultrasound surveillance
• Digital retinal screening
• Discuss birth plan
• Plan for minimising risk of separation of mother and baby
• If steroids required, increase insulin dose by 40%
• Encourage breast feeding
“Time and feeding had expanded that once romantic form; the 
black silk waistcoat had become more and more developed; and 
gradually had the capacious chin encroached upon the borders of 
the white cravat.”
This is how Charles Dickens described Mr Tupman, a character 
in the Pickwick Club.1 Such descriptions would have been unusual 
in the 19th century, but in the 21st century obesity has become a 
major public health problem for adults and children. In response to 
the problem the National Institute for Health and Clinical Excel-
lence (NICE) has issued guidelines on the prevention and man-
agement of obesity, and in turn BMJ Learning has built a module 
based on those guidelines.2
Preventing and managing obesity are complex problems with no 
easy answers, and this module doesn’t offer any. But it is clear on 
some things: diet and exercise are first line treatments and multi-
component interventions are best. It is also clear on what doesn’t 
work: programmes that result in rapid weight loss (faster than 1 
kg a week) are unlikely to be beneficial in the long term, and just 
taking drugs without any thought to diet and lifestyle will not 
work either. There is only one exception to the rule that diet and 
exercise come first—that is for people with severe obesity, those 
with a body mass index greater than 50. For such patients, bariatric 
surgery may be the only intervention that will help them. And in 
terms of assessment the body mass index is still the gold standard, 
although measurement of waist circumference can be helpful too.
The body mass index was invented by the 19th century Belgian 
polymath Adolphe Quetelet, who was writing his scientific thesis 
as Dickens was making fond pen portraits of the pleasantly plump. 
Unless we do something about obesity, it is likely that the work of 
Quetelet will long outlive that of Dickens.
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